SHS Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, SHS has acquired 1 company. It has also invested in 4 others.

SHS’s most common sectors for investment are medical products (52%) and life science (32%). The Firm’s most common investment types include growth capital (60%) and buyout (lbo, mbo, mbi) (20%). In total, SHS has invested in 5 different countries.

In the last 3 years, SHS has exited 4 companies. The Firm’s most common exit type is trade sale (58%). SHS’s largest (disclosed) exit occurred in 2010 when it sold ProBioGen AG for $34M.

Join Mergr to view SHS’s full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity32
    • M&A Buy Activity25
    • M&A Sell Activity7
  • Total Sectors Invested 5
  • Total Countries Invested 5
  • M&A Buy/Sell Connections 5

SHS GmbH

Bismarckstraße 12,
Tübingen, 72072
Germany
+49 7071 91690
www.shs-capital.eu
tuebingen@shs-capital.eu

SHS is a private equity firm focused on the healthcare sector. Specific areas of interest include life science, medical technology, diagnostics, applied technologies, digital health, and industrial biotechnology. The Firm will consider opportunities at all company stages and looks to commit up to €30 million in businesses valued up to €100 million. Target geographies include Germany, Austria, Switzerland, Scandinavia, and Benelux. SHS was established in 1993 and is headquartered in Tubingen, Germany.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Special Situations/Distressed, Secondary Buyout, Stake Purchase, Venture

Geographic Preferences: Western Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size 2 20
Enterprise Value 100 -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.0/yr) # 20 - 1 2 2 - 25
Sell (0.8/yr) # 3 - 1 - 3 - 7
vol $34M $34M
  32

Most Recent M&A

Company Date Value Type
Develco Pharma Schweiz AG 2020-12-17 - Growth Capital
Pratteln, Switzerland · www.develco.ch
Single Use Support Gmbh 2020-12-16 - Add-on Acquisition
Kufstein, Austria · www.susupport.com
Puracon GmbH 2020-12-02 - Add-on Acquisition
Rosenheim, Germany · www.puracon.com
TNI medical AG 2020-03-19 - Add-on Acquisition
Wurzburg, Germany · www.tni-medical.de
Blazejewski MEDITECH GmbH 2020-02-27 - Growth Capital
Sexau, Germany · www.blazejewski.de
Single Use Support Gmbh 2019-11-26 - Stake Purchase
Kufstein, Austria · www.susupport.com
Betterguards Technology GmbH 2019-05-14 - Growth Capital
Berlin, Germany · www.betterguards.de
​evitria AG 2018-12-20 - Buyout (LBO, MBO, MBI)
Zurich, Switzerland · www.evitria.com
Emerging Implant Technologies GmbH 2018-09-17 - Trade Sale
Tuttlingen, Germany · www.eit-spine.de
Puracon GmbH 2016-01-15 - Buyout (LBO, MBO, MBI)
Rosenheim, Germany · www.puracon.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 11 (65%) - 13 (52%) -
Life Science 4 (24%) - 8 (32%) -
Packaging - - 2 (8%) -
Consumer Products 1 (6%) - 1 (4%) -
Healthcare Services 1 (6%) - 1 (4%) -
Total 17 - 25 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
Germany 11 (65%) - 17 (68%) -
Switzerland 5 (29%) - 5 (20%) -
Australia 1 (6%) - 1 (4%) -
Austria - - 1 (4%) -
Czech Republic - - 1 (4%) -
Total 17 - 25 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Growth Capital 13 (76%) - 15 (60%) -
Buyout (LBO, MBO, MBI) 3 (18%) - 5 (20%) -
Stake Purchase 1 (6%) - 3 (12%) -
Secondary Buyout - - 1 (4%) -
Venture - - 1 (4%) -
Total 17 - 25 -

Exits by Deal Type

Type Total # Value
Trade Sale 5 (71%) 34M (100%)
Secondary Sale 1 (14%) -
Trade Sale - Public Company 1 (14%) -
Total 7 $34M

Deal Values

sell # Total
< $100M 1 $34M
TOTAL $34M
Largest ProBioGen AG
$34M (2010-06-14)

M&A Connections

Deals
Acquired from
Investor(s)
4%
1 (4%)
Exited to
Investor(s)
14%
1 (14%)
Strategic(s)
57%
4 (57%)

Investor Summary

Size

Small

Established

1993

Specialist/Generalist

Specialist

Leadership

Bernhard Schirmers

Founder & Managing Partner

Hubertus Leonhardt

Managing Partner

Sascha Alilovic

Managing Partner

Uwe Steinbacher

Managing Partner

Manfred Ulmer-Weber

Partner

 Subscribe to unlock this and 161,439
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 150K M&A Transactions
  • 157K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 48K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal